Digital Therapeutics Market - By Product , By Application , By Geography - Global Opportunity Analysis & Industry Forecast, 2024 - 2030

Report Code: HCR 59791 Report Format: PDF + Excel
Digital Therapeutics Market Overview
 
Digital Therapeutics Market Size is forecast to reach $ 19318.4 Million by 2030, at a CAGR of 20% during forecast period 2024-2030. Rising population along with increasing adoption of smartphones and tablets coupled with healthcare apps, and the rise in the prevalence of chronic disease are major factors driving the Digital Therapeutics Market. Furthermore, digital healthcare and evidence-based therapeutic inventions are also driving this market. With the rapid adoption of innovations and technology, the healthcare industry is set to grow and is contributing to the market. Digital Therapeutic are treatments that are offered through devices such as phones, sensors, apps, and computers. Programs are often based online or are delivered through text messages. They are intended to help patients change their behavior often through strategies such as cognitive-behavioral therapy (CBT) so that they can successfully implement care plans for chronic health or mental health condition.
 
Report Coverage
 
The report: “Digital Therapeutics Market Forecast (2024-2030)”, by IndustryARC, covers an in-depth analysis of the following segments of the Digital Therapeutics Market.
 
By Product: Software, Devices
 
By Application: Preventive Applications, Treatment/Care Related Applications
 
By Sales Channel: B2C, B2B
 
By Geography: North America, Europe, Asia-Pacific, and Rest of the World
 
Key Takeaways
  • The business-to-business sales channel accounted for major share in 2019 owing to the increasing awareness among patients, payers, providers, employers about the benefits provided by digital therapeutics.
  • North America dominated the Digital Therapeutics Market in 2019 owing to the presence of major players in that region.
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the spray gun market report.
  • An increase in the adoption of Smartphones coupled with the rise in healthcare apps is also set to drive the Digital Therapeutics Market in the coming years.
By Application- Segment Analysis 
 
Preventive applications is projected to have the fastest growth rate with CAGR of 13% during the forecast period 2024-2030. However, in 2019, the Diabetes segment dominated the Digital Therapeutics Market owing to the increase in the number of diabetes patients around the world and their willingness to adopt different types of treatment. Rapid urbanization, changing lifestyles, and eating habits are further contributing to its market growth. Moreover, according to the World Health Organization (WHO), the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Technological advancement along with growing innovation such as the Internet of Things (IoT) advanced data analytics have made the wearable medical devices such as smartwatches efficient in the management of chronic disease of diabetes, asthma, and heart diseases the occurrence of which around the world is increasing.
 
By Sales Channel- Segment Analysis
 
By Sales Channel, the Digital Therapeutics Market is segmented into business-to-customer and business-to-business. Among these, the business-to-business accounted for the largest market share in 2019 owing to the increasing awareness among patients, payers, providers, employer about the benefits provided by digital therapeutics. Furthermore, the preference of pharmaceutical companies to combine digital therapeutics with their drug type to offer better services is further driving the Digital Therapeutics Market.
 
Geography- Segment Analysis
 
In 2019, North America dominated the Digital Therapeutics Market share accounting for 37%. Technological advancement along with government initiatives, increasing investments in digital therapeutics is a major factor driving its market growth in that region. Furthermore, the presence of major players such as Evolent Health Inc. and Pear Therapeutics in that region is contributing to its market growth.
 
Drivers –Digital Therapeutics Market
 
Increase in the adoption of smart phones
An increase in the adoption of Smartphones coupled with healthcare apps is a major factor driving the Digital Therapeutics Market during the forecast period 2024-2030. Furthermore, the modern healthcare industry uses various technological innovations so that the patients receive optimum benefits. Moreover, mobile health (mHealth) includes fitness trackers and nutrition apps thereby contributing to the growth of the digital therapeutics market.
 
Increase In The Number Of Diabetes Patients
The increase in the prevalence of diabetes patients and their willingness to adapt to different types of treatment is driving the demand of Digital Therapeutics. Rapid urbanization, changing lifestyle and eating habits,are the major causes of the increase in diabetes among patients. Moreover, according to the World Health Organization about 422 million people worldwide have diabetes particularly in low and middle-income countries and 1.6 million deaths are directly attributed to diabetes each year.
 
Challenges – Digital Therapeutics Market
 
•  Lack Of Awareness & Access To Digital Therapeutic Programs in Developing Countries
Lack of awareness & access to digital therapeutic programs in developing countries is a major factor restraining the Digital Therapeutics Market. Moreover, according to clinical research, U.S. spends 86% of all the healthcare on chronic disease every year, and approximately half of the American population from diseases such as diabetes, obesity, hypertension, smoking, and chronic respiratory disorders. 
 
Digital Therapeutics Market Industry Outlook 
 
Product Launches, Mergers & Acquisitions, joint ventures, and R&D activities are key strategies adopted by the players in the Digital Therapeutics Market. Digital Therapeutics Market top 10 companies are 2morrow Inc., Canary Health Inc., Ginger Io Inc., LivongoHealth, Mango Health Inc., Noom Inc., Omada Health Inc., Propeller Health, Proteus Digital Health Inc. and Welldoc Inc.
 
Developments:
  • January 2020: Pear Therapeutics collaborated with Apricity to advance prescription digital therapeutics to be prescribed in combination with immune-oncology therapy.
  • September 2019: Sanofi collaborated with Happify Health which provides evidence-based mental health digital therapeutics an app to manage and improve psychological outcomes in people with multiple sclerosis.

Key Market Players:

The Top 5 companies in the Digital Therapeutics Market are:

  1. 2morrow Inc.
  2. Canary Health Inc.
  3. Livongo
  4. Mango Health
  5. Omada Health, Inc.
     

For more Lifesciences and Healthcare Market reports, please click here

1. Digital Therapeutics Market Overview
    1.1  Definitions and Scope
2. Digital Therapeutics Market  - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by  Application
    2.3 Key trends by Geography
3. Digital Therapeutics Market –Comparative Analysis
    3.1 Product Benchmarking - Key companies
    3.2 Financials Analysis - Key Companies
    3.3 Market Share Analysis- Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Digital Therapeutics Market- Startup companies Scenario Premium 
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Digital Therapeutics Market – Industry Market Entry Scenario Premium 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Digital Therapeutics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Digital Therapeutics Market -Strategic analysis
    7.1 Value chain analysis 
    7.2 Opportunities analysis
    7.3 Market life cycle
8. Digital Therapeutics Market – By Product (Market Size –$Million/$Billion)
    8.1 Software
    8.2 Devices
9. Digital Therapeutics Market – By Application (Market Size –$Million/$Billion)
    9.1 Preventive Applications
        9.1.1 Pre-diabetes 
        9.1.2 Obesity
    9.2 Treatment/Care Related Applications
        9.2.1 Diabetes
        9.2.2 Central Nervous System (CNS) Disorder
        9.2.3 Chronic Respiratory Diseases (CRS)
        9.2.4 Musculoskeletal Disorder
        9.2.5 Cardiovascular Diseases
        9.2.6 Smoking Cessation
        9.2.7 Medication Adherence
        9.2.8 Other application
10. Digital Therapeutics Market – By Sales Channel (Market Size –$Million/$Billion)
    10.1 B2C
        10.1.1 Caregivers
        10.1.2 Patients
    10.2 B2B
        10.2.1 Providers
        10.2.2 Payers
        10.2.3 Pharmaceutical Companies
        10.2.4 Employers
    10.2.5 Other Buyers
11. Digital Therapeutics Market -  By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1.1 China
        11.3.1.2 Japan
        11.3.1.3 South Korea
        11.3.1.4 India
        11.3.1.5 Australia & New Zealand
        11.3.1.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Digital Therapeutics Market - Entropy
13. Digital Therapeutics Market  – Industry/Segment Competition Landscape 
    13.1. Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Country- Key companies
        13.1.4 Best Practices for Companies
14. Digital Therapeutics Market – Key Company List by Country Premium 
15. Digital Therapeutics Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 2morrow Inc.
    15.3 Canary Health Inc.
    15.4 Ginger Io, Inc.
    15.5 Livongo Health
    15.6 Mango Health Inc
    15.7 Noom Inc.
    15.8 Omada Health, Inc.
    15.9 Propeller Health
    15.10 Proteus Digital Health, Inc
    15.11 Welldoc Inc.
*Financials for private companies would be provided on a best efforts basis”.
 

LIST OF TABLES

1.Global Digital Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
1.1 B2C Market 2023-2030 ($M) - Global Industry Research
1.1.1 Caregiver Market 2023-2030 ($M)
1.1.2 Patient Market 2023-2030 ($M)
1.2 B2B Market 2023-2030 ($M) - Global Industry Research
1.2.1 Provider Market 2023-2030 ($M)
1.2.2 Payer Market 2023-2030 ($M)
1.2.3 Pharmaceutical Company Market 2023-2030 ($M)
1.2.4 Employer Market 2023-2030 ($M)
2.Global Digital Therapeutic Market, By Type Of Application Market 2023-2030 ($M)
2.1 Preventive Application Market 2023-2030 ($M) - Global Industry Research
2.1.1 Prediabetes Market 2023-2030 ($M)
2.1.2 Obesity Market 2023-2030 ($M)
2.2 Treatment/Care-Related Application Market 2023-2030 ($M) - Global Industry Research
2.2.1 Diabetes Market 2023-2030 ($M)
2.2.2 Central Nervous System Disorder Market 2023-2030 ($M)
2.2.3 Chronic Respiratory Disease Market 2023-2030 ($M)
2.2.4 Musculoskeletal Disorder Market 2023-2030 ($M)
2.2.5 Cardiovascular Disease Market 2023-2030 ($M)
2.2.6 Smoking Cessation Market 2023-2030 ($M)
2.2.7 Medication Adherence Market 2023-2030 ($M)
3.Global Digital Therapeutic Market, By Sale Channel Market 2023-2030 (Volume/Units)
3.1 B2C Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Caregiver Market 2023-2030 (Volume/Units)
3.1.2 Patient Market 2023-2030 (Volume/Units)
3.2 B2B Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Provider Market 2023-2030 (Volume/Units)
3.2.2 Payer Market 2023-2030 (Volume/Units)
3.2.3 Pharmaceutical Company Market 2023-2030 (Volume/Units)
3.2.4 Employer Market 2023-2030 (Volume/Units)
4.Global Digital Therapeutic Market, By Type Of Application Market 2023-2030 (Volume/Units)
4.1 Preventive Application Market 2023-2030 (Volume/Units) - Global Industry Research
4.1.1 Prediabetes Market 2023-2030 (Volume/Units)
4.1.2 Obesity Market 2023-2030 (Volume/Units)
4.2 Treatment/Care-Related Application Market 2023-2030 (Volume/Units) - Global Industry Research
4.2.1 Diabetes Market 2023-2030 (Volume/Units)
4.2.2 Central Nervous System Disorder Market 2023-2030 (Volume/Units)
4.2.3 Chronic Respiratory Disease Market 2023-2030 (Volume/Units)
4.2.4 Musculoskeletal Disorder Market 2023-2030 (Volume/Units)
4.2.5 Cardiovascular Disease Market 2023-2030 (Volume/Units)
4.2.6 Smoking Cessation Market 2023-2030 (Volume/Units)
4.2.7 Medication Adherence Market 2023-2030 (Volume/Units)
5.North America Digital Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
5.1 B2C Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Caregiver Market 2023-2030 ($M)
5.1.2 Patient Market 2023-2030 ($M)
5.2 B2B Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Provider Market 2023-2030 ($M)
5.2.2 Payer Market 2023-2030 ($M)
5.2.3 Pharmaceutical Company Market 2023-2030 ($M)
5.2.4 Employer Market 2023-2030 ($M)
6.North America Digital Therapeutic Market, By Type Of Application Market 2023-2030 ($M)
6.1 Preventive Application Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Prediabetes Market 2023-2030 ($M)
6.1.2 Obesity Market 2023-2030 ($M)
6.2 Treatment/Care-Related Application Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Diabetes Market 2023-2030 ($M)
6.2.2 Central Nervous System Disorder Market 2023-2030 ($M)
6.2.3 Chronic Respiratory Disease Market 2023-2030 ($M)
6.2.4 Musculoskeletal Disorder Market 2023-2030 ($M)
6.2.5 Cardiovascular Disease Market 2023-2030 ($M)
6.2.6 Smoking Cessation Market 2023-2030 ($M)
6.2.7 Medication Adherence Market 2023-2030 ($M)
7.South America Digital Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
7.1 B2C Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Caregiver Market 2023-2030 ($M)
7.1.2 Patient Market 2023-2030 ($M)
7.2 B2B Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Provider Market 2023-2030 ($M)
7.2.2 Payer Market 2023-2030 ($M)
7.2.3 Pharmaceutical Company Market 2023-2030 ($M)
7.2.4 Employer Market 2023-2030 ($M)
8.South America Digital Therapeutic Market, By Type Of Application Market 2023-2030 ($M)
8.1 Preventive Application Market 2023-2030 ($M) - Regional Industry Research
8.1.1 Prediabetes Market 2023-2030 ($M)
8.1.2 Obesity Market 2023-2030 ($M)
8.2 Treatment/Care-Related Application Market 2023-2030 ($M) - Regional Industry Research
8.2.1 Diabetes Market 2023-2030 ($M)
8.2.2 Central Nervous System Disorder Market 2023-2030 ($M)
8.2.3 Chronic Respiratory Disease Market 2023-2030 ($M)
8.2.4 Musculoskeletal Disorder Market 2023-2030 ($M)
8.2.5 Cardiovascular Disease Market 2023-2030 ($M)
8.2.6 Smoking Cessation Market 2023-2030 ($M)
8.2.7 Medication Adherence Market 2023-2030 ($M)
9.Europe Digital Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
9.1 B2C Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Caregiver Market 2023-2030 ($M)
9.1.2 Patient Market 2023-2030 ($M)
9.2 B2B Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Provider Market 2023-2030 ($M)
9.2.2 Payer Market 2023-2030 ($M)
9.2.3 Pharmaceutical Company Market 2023-2030 ($M)
9.2.4 Employer Market 2023-2030 ($M)
10.Europe Digital Therapeutic Market, By Type Of Application Market 2023-2030 ($M)
10.1 Preventive Application Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Prediabetes Market 2023-2030 ($M)
10.1.2 Obesity Market 2023-2030 ($M)
10.2 Treatment/Care-Related Application Market 2023-2030 ($M) - Regional Industry Research
10.2.1 Diabetes Market 2023-2030 ($M)
10.2.2 Central Nervous System Disorder Market 2023-2030 ($M)
10.2.3 Chronic Respiratory Disease Market 2023-2030 ($M)
10.2.4 Musculoskeletal Disorder Market 2023-2030 ($M)
10.2.5 Cardiovascular Disease Market 2023-2030 ($M)
10.2.6 Smoking Cessation Market 2023-2030 ($M)
10.2.7 Medication Adherence Market 2023-2030 ($M)
11.APAC Digital Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
11.1 B2C Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Caregiver Market 2023-2030 ($M)
11.1.2 Patient Market 2023-2030 ($M)
11.2 B2B Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Provider Market 2023-2030 ($M)
11.2.2 Payer Market 2023-2030 ($M)
11.2.3 Pharmaceutical Company Market 2023-2030 ($M)
11.2.4 Employer Market 2023-2030 ($M)
12.APAC Digital Therapeutic Market, By Type Of Application Market 2023-2030 ($M)
12.1 Preventive Application Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Prediabetes Market 2023-2030 ($M)
12.1.2 Obesity Market 2023-2030 ($M)
12.2 Treatment/Care-Related Application Market 2023-2030 ($M) - Regional Industry Research
12.2.1 Diabetes Market 2023-2030 ($M)
12.2.2 Central Nervous System Disorder Market 2023-2030 ($M)
12.2.3 Chronic Respiratory Disease Market 2023-2030 ($M)
12.2.4 Musculoskeletal Disorder Market 2023-2030 ($M)
12.2.5 Cardiovascular Disease Market 2023-2030 ($M)
12.2.6 Smoking Cessation Market 2023-2030 ($M)
12.2.7 Medication Adherence Market 2023-2030 ($M)
13.MENA Digital Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
13.1 B2C Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Caregiver Market 2023-2030 ($M)
13.1.2 Patient Market 2023-2030 ($M)
13.2 B2B Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Provider Market 2023-2030 ($M)
13.2.2 Payer Market 2023-2030 ($M)
13.2.3 Pharmaceutical Company Market 2023-2030 ($M)
13.2.4 Employer Market 2023-2030 ($M)
14.MENA Digital Therapeutic Market, By Type Of Application Market 2023-2030 ($M)
14.1 Preventive Application Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Prediabetes Market 2023-2030 ($M)
14.1.2 Obesity Market 2023-2030 ($M)
14.2 Treatment/Care-Related Application Market 2023-2030 ($M) - Regional Industry Research
14.2.1 Diabetes Market 2023-2030 ($M)
14.2.2 Central Nervous System Disorder Market 2023-2030 ($M)
14.2.3 Chronic Respiratory Disease Market 2023-2030 ($M)
14.2.4 Musculoskeletal Disorder Market 2023-2030 ($M)
14.2.5 Cardiovascular Disease Market 2023-2030 ($M)
14.2.6 Smoking Cessation Market 2023-2030 ($M)
14.2.7 Medication Adherence Market 2023-2030 ($M)

LIST OF FIGURES

1.US Digital Therapeutics Market Revenue, 2023-2030 ($M)
2.Canada Digital Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico Digital Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil Digital Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina Digital Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru Digital Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia Digital Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile Digital Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America Digital Therapeutics Market Revenue, 2023-2030 ($M)
10.UK Digital Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany Digital Therapeutics Market Revenue, 2023-2030 ($M)
12.France Digital Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy Digital Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain Digital Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Digital Therapeutics Market Revenue, 2023-2030 ($M)
16.China Digital Therapeutics Market Revenue, 2023-2030 ($M)
17.India Digital Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan Digital Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea Digital Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa Digital Therapeutics Market Revenue, 2023-2030 ($M)
21.North America Digital Therapeutics By Application
22.South America Digital Therapeutics By Application
23.Europe Digital Therapeutics By Application
24.APAC Digital Therapeutics By Application
25.MENA Digital Therapeutics By Application
26.Proteus Digital Health, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Omada Health, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Welldoc, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Livongo Health, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Noom Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Ginger Io, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Propeller Health, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.2Morrow Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Canary Health Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Mango Health Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)